REBUILD: Exercise tolerance & Pulmonary Fibrosis Study

 

Trial Objective

GettyImages-185243058Q.jpgResearchers want to know if inhaled nitric oxide delivered to the lungs will improve exercise tolerance and overall wellbeing of people with pulmonary fibrosis. Participants in the REBUILD study will use an investigational device called INOpulse to inhale nitric oxide every day. They also will wear a wrist monitor to track activity. If needed, transportation to study appointments may be provided.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Patients with pulmonary fibrosis who are receiving oxygen therapy.

Age: 18-80    Gender: Any Gender


Estimated Time Commitment

5 visits over 16 weeks



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Available

Trial Contact

For more information, contact:

Jennifer Underwood
303-398-1518

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Bellerophon

Principal Investigators


Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.


*
*
*
*
 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: